In8bio Historical Cash Flow

INAB Stock  USD 0.30  0.01  3.23%   
Analysis of In8bio cash flow over time is an excellent tool to project In8bio Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 14.6 M or Other Cashflows From Financing Activities of 4.5 M as it is a great indicator of In8bio ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining In8bio Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether In8bio Inc is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About In8bio Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in In8bio balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which In8bio's non-liquid assets can be easily converted into cash.

In8bio Cash Flow Chart

At present, In8bio's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 4.5 M, whereas Investments are forecasted to decline to (630 K).

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by In8bio Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of In8bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from In8bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into In8bio Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, In8bio's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 4.5 M, whereas Investments are forecasted to decline to (630 K).

In8bio cash flow statement Correlations

0.720.2-0.340.51-0.01-0.66-0.17-0.84-0.97-0.030.520.150.4-0.11-0.30.520.07
0.720.16-0.270.41-0.31-0.51-0.19-0.59-0.8-0.110.330.550.340.28-0.13-0.07-0.06
0.20.16-0.870.89-0.34-0.85-0.77-0.25-0.31-0.960.39-0.680.91-0.82-0.930.47-0.54
-0.34-0.27-0.87-0.970.240.830.960.120.410.76-0.640.57-0.980.70.97-0.670.77
0.510.410.89-0.97-0.31-0.93-0.88-0.35-0.59-0.780.6-0.510.99-0.69-0.950.65-0.65
-0.01-0.31-0.340.24-0.310.170.250.090.170.530.5-0.04-0.36-0.070.180.240.29
-0.66-0.51-0.850.83-0.930.170.660.620.720.72-0.640.42-0.880.680.85-0.60.38
-0.17-0.19-0.770.96-0.880.250.66-0.130.240.68-0.590.52-0.920.590.9-0.580.89
-0.84-0.59-0.250.12-0.350.090.62-0.130.860.17-0.2-0.09-0.230.170.17-0.25-0.41
-0.97-0.8-0.310.41-0.590.170.720.240.860.18-0.45-0.17-0.490.120.36-0.42-0.05
-0.03-0.11-0.960.76-0.780.530.720.680.170.18-0.140.62-0.810.710.82-0.250.5
0.520.330.39-0.640.60.5-0.64-0.59-0.2-0.45-0.14-0.220.56-0.44-0.610.67-0.4
0.150.55-0.680.57-0.51-0.040.420.52-0.09-0.170.62-0.22-0.550.940.72-0.650.42
0.40.340.91-0.980.99-0.36-0.88-0.92-0.23-0.49-0.810.56-0.55-0.7-0.960.63-0.73
-0.110.28-0.820.7-0.69-0.070.680.590.170.120.71-0.440.94-0.70.85-0.730.38
-0.3-0.13-0.930.97-0.950.180.850.90.170.360.82-0.610.72-0.960.85-0.710.68
0.52-0.070.47-0.670.650.24-0.6-0.58-0.25-0.42-0.250.67-0.650.63-0.73-0.71-0.39
0.07-0.06-0.540.77-0.650.290.380.89-0.41-0.050.5-0.40.42-0.730.380.68-0.39
Click cells to compare fundamentals

In8bio Account Relationship Matchups

In8bio cash flow statement Accounts

201920202021202220232024 (projected)
Investments356K0.0(309K)(3.7M)(600K)(630K)
Change In Cash(4.4M)17.4M19.1M(18.8M)2.8M2.8M
Stock Based Compensation76K357K2.2M3.5M4.4M4.6M
Free Cash Flow(5.1M)(7.1M)(13.8M)(27.8M)(23.9M)(22.7M)
Change In Working Capital93K611K(1.8M)(170K)(204K)(214.2K)
Begin Period Cash Flow5.0M610K18.1M37.3M18.4M14.6M
Other Cashflows From Financing Activities65.023.8M(2.7M)61K3.3M4.5M
Other Non Cash Items68K368K541.0K4.2M(981K)(932.0K)
Total Cash From Operating Activities(4.8M)(7.1M)(13.5M)(24.1M)(23.3M)(22.2M)
Issuance Of Capital Stock0.025.7M36.3M9.5M24.6M18.9M
Net Income(5.1M)(8.6M)(14.7M)(28.5M)(30.0M)(28.5M)
Total Cash From Financing Activities65K24.5M33.0M9.0M27.0M18.7M
End Period Cash Flow610K18.0M37.3M18.4M21.3M18.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74)
Return On Assets
(0.78)
Return On Equity
(1.80)
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.